期刊文献+

山莨菪碱在腹膜透析治疗中的应用

Application of Anisodamine in Peritoneal Dialysis
原文传递
导出
摘要 目的观察山莨菪碱注射液对腹膜透析(peritoneal dialysis,PD)患者腹膜转运功能的影响。方法选择22例我院腹膜透析住院患者,给予山莨菪碱注射液10 mg/d,静脉滴注1周。采用腹膜平衡试验(peritoneal equilibration test,PET)评估患者的腹膜转运功能。用自身前后对照研究方法,观察患者山莨菪碱注射液治疗前后腹膜转运功能的变化。结果患者腹膜转运功能(PET)绝大多数有明显提升,有高度显著性差异(P<0.01)。同时,观察到有9例腹膜透析患者经山莨菪碱注射液治疗后血磷下降,2.32±0.246 mmol/L vs 1.95±0.185 mmol/L,有显著性差异(P<0.05)。而血白蛋白下降不明显,无统计学意义。结论山莨菪碱注射液经济、实用,在提高患者腹膜透析转运功能、降低血磷方面有很好的应用价值。 Objective To observe the effect of anisodamine Injection on peritoneal transport function of patients with peritoneal dialysis( PD). Methods A total of 22 inpatients with peritoneal dialysis in our hospital were selected and given anisodamine injection 10 mg/d,intravenously for one week. Afterwards,a peritoneal balance test( PET) was used to evaluate patients’ peritoneal transport function. By comparing the PET values before and after anisodamine injection,we can assess the changes of peritoneal transport function of patients. Results Most patients have significantly improved their peritoneal transport function,P<0.01,with significant difference between before and after. Furthermore,decreased blood phosphorus after anisodamine injection treatment was observed among nine patients(2.32±0.246 mmol/L vs 1.95±0.185 mmol/L),P<0.05,with significant difference.However,no significant decrease in albumin was detected. Conclusion Anisodamine injection is economical,practical and of potential application value in improving transport function and reducing blood phosphorus of patients.
作者 周召协 徐长远 吴云科 田金霞 ZHOU Zhao-xie;XU Chang-yuan;WU Yun-ke;TIAN Jin-xia(Department of Nephrology,People's Hospital of Jishou City,Jishou Hunan 416000,China)
出处 《透析与人工器官》 2020年第1期23-25,共3页 Chinese Journal of Dialysis and Artificial Organs
关键词 山莨菪碱 腹膜透析 腹膜转运功能 腹膜平衡试验 血磷 Anisodamine Peritoneal dialysis Peritoneal transport function Peritoneal balance test Blood phosphorus
  • 相关文献

参考文献5

二级参考文献26

  • 1蒋子栋,刘稳,赵翠霞,张连山.山莨菪碱辅助治疗急性分泌性中耳炎的临床研究[J].临床耳鼻咽喉科杂志,2004,18(7):406-407. 被引量:14
  • 2杨藻宸.医用药理学(第1版)[M].北京:人民卫生出版社,1992.163. 被引量:1
  • 3FU Xiang-hua FAN Wei-ze GU Xin-shun WEI Yong-yun JIANG Yun-fa WU Wei-li LI Shi-qiang HAO Guo-zhen WEI Qing-min XUE Ling.Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction[J].Chinese Medical Journal,2007(14):1226-1231. 被引量:38
  • 4唐朝枢,杨晓红,王宪,等.山莨菪碱(654-2)的钙拮抗作用[A].中国中西医结合研究会微循环专业委员会第一届学术交流会资料[C].0001. 被引量:1
  • 5Esberg LB,Ren J.The oxygen radical generator pyrogallol impairs cardiomyocyte contractile function via a superoxide and p38 MAP kinase-dependent pathway:protection by anisodamine and tetramethyipyrazine[J].Cardiovasc Toxicol,2004,4(4):375-384. 被引量:1
  • 6Wci Y,Li J,Zhu C,et al.2-O-(2-Hydroxybutyl)-betacyclodextrin as a chiral selector for the capillary electro-phoretic separation ofchiral drugs[J].Anal Sci,2005,21(8):959-962. 被引量:1
  • 7Yang LM,Xie YF,Chen HZ,el al.Diastereomeric and enantiomeric high-performance liquid chromatographic separation of synthetic anisodamine[J].J Pharm Biomed Anal,2007,43(3):905-909. 被引量:1
  • 8Fan GR,Hong ZY,Lin M,et al.Study of stereoselective pharmacokinetics of anisodamine enantiomers in rabbits by capillary electrophoresis[J].J Chromatogr B Analyt Technol BiomedLifeSci,2004,809(2):265-271. 被引量:1
  • 9Wang H,Lu Y Chen HZ.Differentiating effects of anisodamine on cognitive amelioration and peripheral muscarinic side effects induced by pilocarpine in mice[J].Neurosci Lett,2003.344(3):173-176. 被引量:1
  • 10Zhang WW Xu ZP,Cui YY,et al Peripheral cholinoceptor antagonist anisodamine counteracts cholinergic adverse effects and facilitates cognitive amelioration of rivastigmine[J].J Neural Transm,2009,116(12):1643-1649. 被引量:1

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部